Background Renal medullary carcinoma is a rare renal malignancy of childhood. There are no large series describing the imaging appearance of renal medullary carcinoma in children.
lymphangitic carcinomatosis had associated enlarged mediastinal lymph nodes. Conclusion Renal medullary carcinoma in children and young adults presents at an advanced local and distant stage in the majority of patients. The diagnosis of renal medullary carcinoma should be considered when a child or young adult presents with a poorly defined/infiltrative, centrally located renal mass, especially in the setting of known sickle cell hemoglobinopathy. Distant metastases are common at initial presentation in the lungs, distant lymph nodes and liver and often involve multiple sites simultaneously. Pulmonary lymphangitic
Introduction
Renal medullary carcinoma is a rare, aggressive malignancy that occurs most commonly in adolescents and young adults with sickle cell hemoglobinopathy [1] . It typically arises in the renal medulla, perhaps secondary to sickling-induced hypoxia promoting the expression of hypoxia inducible factor and vascular endothelial growth factor [2] . Significant advances have been made in the management of pediatric renal tumors, but the prognosis of children with renal medullary carcinoma continues to be dismal [3] . Patients with renal medullary carcinoma almost always present with metastatic disease and have a tumor-related mortality of 95% [4, 5] . The most common clinical presentation of renal medullary carcinoma is hematuria and flank pain. The clinical and imaging findings of renal medullary carcinoma can mimic pyelonephritis, which can result in delayed diagnosis [2, 4] . Since its original description in 1995, the imaging findings of renal medullary carcinoma have been described in case reports and small case series [6] [7] [8] .
The purpose of our study was to review the imaging patterns of local and distant disease at presentation in a large cohort of children with renal medullary carcinoma.
Materials and methods
The study cohort was comprised of patients with renal medullary carcinoma who were enrolled in the Children's Oncology Group renal tumors classification, biology and banking study (protocol AREN03B2) between March 2006 and August 2016. The protocol was HIPAA compliant and approved by the National Cancer Institute Pediatric Central Institutional Review Board (PCIRB), as well as by local institutional review boards, if applicable. All patients/guardians signed informed assent/consent as appropriate. As of August 1, 2016, 5,490 renal tumor cases of all types had been enrolled in AREN03B2. All tumors were reviewed centrally by one of two expert pediatric pathologists (M.M.C. and E.J.P. with 11 and 27 years of post-fellowship experience, respectively) and they confirmed the histological diagnosis of renal medullary carcinoma.
At the time of enrollment, the institution was required to submit a contrast-enhanced CT or contrast-enhanced MRI study of the abdomen and pelvis for central imaging review by study radiologists. The minimum imaging requirements were slice thickness of 5 mm or less and portal venous phase imaging of the abdomen/pelvis. A chest CT was also required at enrollment with a maximum slice thickness of 5 mm. The chest CT could be performed with or without intravenous contrast. Local institutions were also required to submit operative notes and pathology slides from biopsy or nephrectomy specimens for central review by the study surgeons and pathologists, respectively.
All imaging studies for this retrospective review were reviewed by a pediatric radiologist with 13 years of experience (G.K.) and a radiology resident by consensus (J.K.S.), respectively. This review was performed blinded to the institutional report and the initial central radiology review. The radiology reviewers assessed the anatomical location, size, margin, homogeneity and contrast enhancement of the renal mass with respect to the normal renal parenchyma. Tumor dimensions were measured in the axial plane (longest diameter and orthogonal measurement) and maximum cephalocaudal dimension, and the volume was determined by using the formula for an ellipse (product of 3 dimensions×0.52). Tumors were characterized as well demarcated if the margin between the mass and normal parenchyma could be clearly delineated circumferentially and infiltrating if the margins were obscure. Areas of calcification within the tumor were noted. The location of the tumor with respect to the pelvicalyceal system was also recorded.
Enlarged lymph nodes (>1 cm in short axis) were noted [9] . Liver metastasis was defined as focal hypoenhancing lesions in the liver parenchyma. Chest CTs were evaluated in all patients to determine the presence of pulmonary nodules. Intrafissural nodules <1 cm were characterized as benign lymph nodes and peripheral linear opacities were noted to represent atelectasis. Pulmonary nodules were further categorized as having distinct margins, indistinct margins and pattern of pulmonary lymphangitic carcinomatosis (pulmonary lymphangitic carcinomatosis). Pulmonary lymphangitic carcinomatosis was defined as smooth or nodular thickening of the peribronchovascular interstitium, interlobular septa and/or subpleural interstitium.
Staging was reviewed by the study oncologists (E.A.M. and J.I.G. with 19 and 13 years of post-fellowship experience, respectively) after central pathology, imaging and surgery were complete, according to American Joint Committee on Cancer tumor/nodes/metastasis (TNM) staging criteria [10] .
Results
As of August 1, 2016, 26 cases of renal medullary carcinoma were enrolled in AREN03B2. Thirteen of these cases have been included in a prior report on pediatric renal cell carcinoma, but the subset of patients' renal medullary carcinoma was not specifically characterized in this publication [11] . In the current cohort of 26 cases, abdominal imaging was performed with CT in 23 cases, both CT and MR in 2 cases and with MR alone in 1 case. One case had non-contrast abdomenpelvis CT and was excluded from further review. Chest CT was available for central review in all cases; 22 cases had a contrast-enhanced CT of the chest while in 3 cases the chest CT was performed without intravenous contrast.
Clinical features
The clinical data of this cohort is summarized in Table 1 . Patients ranged in age from 6 to 21 years (mean: 13 years, median: 13 years). There was a predilection for males, with a male to female ratio of 3.2:1. Sickle cell status was reported in 13 cases: Ten patients had sickle cell trait and 3 had sickle cell disease.
Initial clinical presentation was available for 23/25 patients. Common clinical presentations included flank/abdominal pain (n=12) and/or hematuria (n=11). Other presenting symptoms included weight loss (n=5), respiratory symptoms (cough/ chest/respiratory distress) (n=5), hypertension (n=2), scrotal pain (n=2), fever (n=2), urinary tract infection (n=1) and enlarging neck mass (n=1). The stage of disease at initial presentation based on central risk assignment was as follows: stage 1: n=1, stage 2: n=2, stage 4: n=22.
Imaging findings Primary mass
The renal mass arose from the right kidney in 15 cases and the left kidney in 10 cases. There were no bilateral or multifocal renal masses. The maximum dimension of the renal mass in axial plane ranged from 1.6 to 10.3 cm (median: 6.6 cm, mean: 6.6 cm). Average tumor volume was estimated at 173 cm 3 (range: 1.5-644 cm 3 ). In all cases, the mass demonstrated decreased enhancement as compared to the normal renal parenchyma. The margins of the tumor were infiltrating in 21/25 (84%) cases and well-demarcated in 4 (16%) (Figs. 1  and 2 ). The renal mass abutted the pelvicalyceal system in all but one case. Small areas of calcification were present in only 3/25 (12%) cases. Twenty-three of the 25 cases had solid masses, while 2 masses were predominantly cystic. Hypoenhancing areas representing Nx regional lymph nodes cannot be assessed, N1 metastasis in regional lymph nodes, N2 metastasis in distant lymph nodes, Tx primary tumor cannot be assessed, T1 tumor ≤7 cm in greatest dimension limited to the kidney, T3 tumor extends into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond the Gerota fascia, T4 tumor invades beyond the Gerota fascia (including contiguous extension into the ipsilateral adrenal gland) [10] hypovascular regions of the tumor were identified in all except one case. This single case had a very subtle, small, poorly enhancing renal lesion with large retroperitoneal lymph nodes (Fig. 1) .
Locoregional metastases based on imaging
Enlarged (>1 cm in short axis) retroperitoneal lymph nodes were identified at initial staging CT in 20/25 (80%) of cases. Metastatic lymph node involvement was pathologically confirmed by surgical sampling in 11/20 cases, while the other 9 did not have retroperitoneal lymph node sampling. Eleven of the 13 patients with pathological proof of lymph node involvement had enlarged lymph nodes on imaging (>1 cm). In two cases, the lymph nodes were not enlarged on imaging. Liver metastasis, identified as hypodense liver lesions, was present at initial presentation in 6/25 cases (24%). All patients with liver metastases had lung metastases as well. One case had drop metastasis in the pelvis at initial staging.
Chest imaging
Lung metastases were present on initial staging CT in 19/25 (76%) of cases. The pattern of lung metastasis was lymphangitic carcinomatosis: 10 cases (9 bilateral, 1 unilateral), pulmonary nodules with indistinct margins: 6 cases, pulmonary nodules with distinct margins: 2 cases and 1 case had pulmonary nodules with both indistinct and distinct margins. The pulmonary lymphangitic carcinomatosis was characterized by smooth septal line thickening in 3 cases, nodular septal line thickening in 3 cases, and thickening of the peribronchovascular interstitium in all 10 cases (Figs. 3, 4 and 5). Pulmonary lymphangitic carcinomatosis was pathologically confirmed in 4/10 cases, with a median time interval of 4 days between imaging and lung biopsy. All 10 cases with pulmonary lymphangitic carcinomatosis by imaging had associated mediastinal lymphadenopathy.
Mediastinal lymphadenopathy was present at initial presentation in 14/25 (56%) of cases, while 4/25 (16%) had supraclavicular lymphadenopathy at presentation as well.
Discussion
Renal medullary carcinoma is a rare subtype of renal cell carcinoma that was first described as the seventh sickle cell nephropathy [1] . Similar to prior studies, we found a slight predilection for males over females and right over left kidney. There also was a strong association with sickle cell hemoglobinopathy: 10 had sickle cell trait, 3 had sickle cell disease and 12 had unknown sickle cell status. A number of cases of renal medullary carcinoma in individuals without sickle cell disease/trait, including in Caucasians, have been reported in prior studies [4, 7] . As previously reported, abdominal pain and hematuria were the most common presenting complaints in our cohort. Some cases, however, presented with symptoms related to metastatic disease, such as respiratory symptoms and palpable lymphadenopathy. The most common imaging appearance of renal medullary carcinoma in our series was a poorly marginated, infiltrating mass abutting the pelvicalyceal system. The hypoxic environment of the renal papillae secondary to sickling has been postulated to play a role in the pathogenesis of renal medullary carcinoma [2] . Though other pediatric renal masses such as cystic nephromas can closely abut and extend into the renal pelvis/collecting system, these masses are typically associated with a pseudocapsule/welldefined margins [12] .
The vast majority (88%) of cases in our series had stage IV disease at presentation with the most common sites of distant metastasis being the lungs and mediastinal lymph nodes. Pulmonary metastases in children secondary to most solid tumors are typically bloodborne and have distinct margins. The presence of indistinct margins is generally favored to represent an inflammatory process over malignancy in the pediatric patient with a known solid tumor [13] . Indistinct margins around pulmonary metastasis can occur secondary to peritumoral hemorrhage as seen in hemorrhagic metastasis from choriocarcinoma and angiosarcoma. In our cohort of pediatric renal medullary carcinoma, we found that lung metastasis had an atypical imaging appearance with the most common pattern being of pulmonary lymphangitic carcinomatosis and nodules with indistinct margins being more common than nodules with distinct margins.
Pulmonary lymphangitic carcinomatosis refers to tumor growth in the pulmonary lymphatic system and secondary obstruction of the lymphatic channels. Invasion and retrograde tumor seeding in lymphatic and perilymphatic interstitium result in the characteristic CT findings of pulmonary The patient died due to disease progression 10 months after the initial diagnosis lymphangitic carcinomatosis, which can be focal/unilateral or diffuse. Pulmonary lymphangitic carcinomatosis may involve mainly the axial interstitium, leading to thickening of the bronchovascular bundles, or mainly the peripheral interstitium, leading to thickening of the interlobular septa. Interstitial thickening can be smooth or nodular. However, the normal parenchymal architecture of the pulmonary lobule is preserved. Associated hilar/mediastinal lymphadenopathy is present in 50% of the cases, and ipsilateral pleural effusion may also be present. It is characterized clinically by the presence of progressive dyspnea and cough, nonspecific clinical findings that can be mistaken for infection or pulmonary edema [14] . Pulmonary lymphangitic carcinomatosis is typically seen in adults secondary to underlying malignancies such as adenocarcinoma of the lungs, breast or gastrointestinal system. These malignancies are very uncommon in the pediatric population. In the pediatric population, pulmonary lymphangitic carcinomatosis has been reported in a case with metastatic osteosarcoma [15] . The findings of interstitial thickening on CT may be mistaken for pulmonary edema and not recognized as metastatic disease. The presence of nodular thickening of the interlobular septa (beaded septum sign) is very specific for lymphangitic carcinomatosis. In this cohort, 40% of cases had imaging findings of pulmonary lymphangitic carcinomatosis. We are not certain as to the etiology of this, given that this pattern is uncommon in pediatric malignancies, but speculate that the aggressive, infiltrative growth pattern of renal medullary carcinoma with its propensity of lymphatic invasion makes pulmonary lymphangitic carcinomatosis more common in this patient population.
The major limitation of our study is that the diagnosis of pulmonary lymphangitic carcinomatosis was not proven by biopsy in all cases. However, the imaging appearance of pulmonary lymphangitic carcinomatosis is very characteristic and different from hematogeneous metastasis. All patients in this cohort determined to have lung metastasis were designated to have stage IV disease per the local institution at institutional review and at central review. Secondly, retroperitoneal lymph node sampling was not uniformly performed in all cases, resulting in a large proportion of Nx (lymph nodes cannot be evaluated) cases even though imaging demonstrated bulky retroperitoneal lymph nodes. Failure to perform lymph node sampling is a commonly reported surgical protocol violation in pediatric renal tumors [16] . Third, we have described the imaging findings of the primary mass on CT. Sonography is the recommended imaging modality for the initial evaluation of renal tumors. In the Children's Oncology Group AREN03B2 study, local US images were not centrally reviewed and hence were not available for this study. Also, the choice of CT vs. MRI was at the discretion of the treating institution and only 3/25 cases underwent evaluation of the primary mass with MRI. Another limitation of our study is the lack of complete data on sickle cell status in all cases as this was not a requirement on the original case report forms submitted by the institutions at the time of enrollment.
Conclusion
Renal medullary carcinoma tends to present as an infiltrating, hypoenhancing renal mass arising from the renal medulla, which closely abuts the renal pelvis. Distant metastases are common at initial presentation in the lungs, distant lymph nodes and liver, and often involve multiple sites simultaneously. Pulmonary metastases are often secondary to lymphangitic spread of tumor resulting in characteristic imaging findings that should not be mistaken for nonspecific edema or infection. 
